In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept - statnews.com
In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept statnews.com
Pancreatic Cancer News
A new drug targets one of cancer’s master switches - The Economist
A new drug targets one of cancer’s master switches The Economist
Dr. Roach: Parkinson's patient gets mixed advice on surgery for cancer - The Detroit News
Dr. Roach: Parkinson's patient gets mixed advice on surgery for cancer The Detroit News
Eric Roy: Brest manager dies aged 58 after pancreatic cancer diagnosis - BBC
Eric Roy: Brest manager dies aged 58 after pancreatic cancer diagnosis BBC
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis - Nature
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis Nature
Vitamin D shows promise for hard-to-treat pancreatic cancers - The Seattle Times
Vitamin D shows promise for hard-to-treat pancreatic cancers The Seattle Times
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer - Elicio Therapeutics
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer Elicio Therapeutics
Stage 4 pancreatic cancer: Lewis' story - Roswell Park Comprehensive Cancer Center
Stage 4 pancreatic cancer: Lewis' story Roswell Park Comprehensive Cancer Center
Verastem Oncology’s pancreatic cancer combo shows 86% OS rate - Clinical Trials Arena
Verastem Oncology’s pancreatic cancer combo shows 86% OS rate Clinical Trials Arena
Can AI Enhance Non-Contrast and Contrast-Enhanced CT Detection of Pancreatic Cancer? - diagnosticimaging.com
Can AI Enhance Non-Contrast and Contrast-Enhanced CT Detection of Pancreatic Cancer? diagnosticimaging.com
Daraxonrasib in Pancreatic Cancer: What Oncology Nurses Need to Know - Oncology Nursing News
Daraxonrasib in Pancreatic Cancer: What Oncology Nurses Need to Know Oncology Nursing News
2 major advances fuel new optimism in pancreatic cancer care - Mayo Clinic
2 major advances fuel new optimism in pancreatic cancer care Mayo Clinic
Dr Ahn on Phase 2a Data With Atebimetinib and Chemotherapy in Pancreatic Cancer - OncLive
Dr Ahn on Phase 2a Data With Atebimetinib and Chemotherapy in Pancreatic Cancer OncLive
Verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by Revolution - BioSpace
Verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by Revolution BioSpace
A new pancreatic cancer drug is changing survival rates for one of the deadliest cancers - UCHealth
A new pancreatic cancer drug is changing survival rates for one of the deadliest cancers UCHealth
Elicio Reports Three Complete Responses With ELI-002 7P in Metastatic Pancreatic Cancer - The Clinical Trial Vanguard
Elicio Reports Three Complete Responses With ELI-002 7P in Metastatic Pancreatic Cancer The Clinical Trial Vanguard
Previously Unknown Mechanism Makes Pancreatic Cancer Vulnerable to Cell Death - Technology Networks
Previously Unknown Mechanism Makes Pancreatic Cancer Vulnerable to Cell Death Technology Networks
KRAS and Pancreatic Cancer: Entering a New Era of Treatment - Thursday, 6/25 - Pancreatic Cancer Action Network
KRAS and Pancreatic Cancer: Entering a New Era of Treatment - Thursday, 6/25 Pancreatic Cancer Action Network
Q&A: What does the new ‘game-changer’ pill offer pancreatic cancer patients? - UVA Today
Q&A: What does the new ‘game-changer’ pill offer pancreatic cancer patients? UVA Today
Treating pancreatic tumours may have revealed cancer’s master switch - The Economist
Treating pancreatic tumours may have revealed cancer’s master switch The Economist
Everyday Health: Groundbreaking Drug May Double Survival Time for Pancreatic Cancer - Cedars-Sinai
Everyday Health: Groundbreaking Drug May Double Survival Time for Pancreatic Cancer Cedars-Sinai
Promising new treatment for pancreatic cancer doubles survival rates - PBS
Promising new treatment for pancreatic cancer doubles survival rates PBS
Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models - Genetic Engineering and Biotechnology News
Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models Genetic Engineering and Biotechnology News
AI models match physicians in pancreatic cancer detection on CT - AuntMinnie
AI models match physicians in pancreatic cancer detection on CT AuntMinnie
First-Line Treatment Decisions in Metastatic Pancreatic Cancer: Setting the Stage - OncLive
First-Line Treatment Decisions in Metastatic Pancreatic Cancer: Setting the Stage OncLive
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer - Harvard Medical School
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer Harvard Medical School
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer - Yahoo Finance
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer Yahoo Finance
Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer - Fierce Pharma
Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer Fierce Pharma
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy - Fred Hutchinson Cancer Center
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy Fred Hutchinson Cancer Center
Opinion | Celebrating new tools in the fight against cancer - Alabama Political Reporter
Opinion | Celebrating new tools in the fight against cancer Alabama Political Reporter
Landmark pancreatic cancer treatment paves way for targeting other tricky tumors - Scientific American
Landmark pancreatic cancer treatment paves way for targeting other tricky tumors Scientific American
Scientists Have Linked Alcohol Consumption to Another Form of Cancer - EatingWell
Scientists Have Linked Alcohol Consumption to Another Form of Cancer EatingWell
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope - Memorial Sloan Kettering Cancer Center
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope Memorial Sloan Kettering Cancer Center
Pancreatic cancer was once considered almost untreatable. A new drug is offering hope - NPR
Pancreatic cancer was once considered almost untreatable. A new drug is offering hope NPR
One fat helped pancreatic cancer grow while another cut disease in half - ScienceDaily
One fat helped pancreatic cancer grow while another cut disease in half ScienceDaily
GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk - Medical News Today
GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk Medical News Today
AIM ImmunoTech clears final dose milestone in pancreatic cancer trial - Stock Titan
AIM ImmunoTech clears final dose milestone in pancreatic cancer trial Stock Titan
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease - The Conversation
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease The Conversation
Daraxonrasib Doubles Survival in Pancreatic Cancer at ASCO 2026: A Game-Changer - Oncology News Central
Daraxonrasib Doubles Survival in Pancreatic Cancer at ASCO 2026: A Game-Changer Oncology News Central
Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival - Cedars-Sinai
Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival Cedars-Sinai